Status: current, Primitive. Date: 29-Feb 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1520871000168115 | Idarubicin (Aspen) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1520881000168117 | Idarubicin (Aspen) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Idarubicin (Aspen) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Idarubicin (Aspen) 10 mg/10 mL injection, 10 mL vial | has TP | True | Idarubicin (Aspen) | Inferred relationship | Some | |
| Idarubicin (Aspen) 5 mg/5 mL injection, 5 mL vial | Is a | True | Idarubicin (Aspen) | Inferred relationship | Some | |
| Idarubicin (Aspen) 5 mg/5 mL injection, 5 mL vial | has TP | True | Idarubicin (Aspen) | Inferred relationship | Some | |
| Idarubicin (Aspen) 10 mg/10 mL injection, 10 mL vial | has TP | True | Idarubicin (Aspen) | Inferred relationship | Some | |
| Idarubicin (Aspen) 10 mg/10 mL injection, 10 mL vial | Is a | True | Idarubicin (Aspen) | Inferred relationship | Some | |
| Idarubicin (Aspen) 5 mg/5 mL injection, 5 mL vial | has TP | True | Idarubicin (Aspen) | Inferred relationship | Some |
Reference Sets
FHIR